Search Results for “Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking” – Page 35

Refined treatment resonse criteria for indolent systemic mastocytosis proposed by the ECNM-AIM consortium

188.

Pyatilova, P., Akin, C., Alvarez-Twose, I., Arock, M., Bonadonna, P., Brockow, K., Butterfield, J. H., Broesby-Olsen, S., Carter, M. C., Castells, M., George, T. I., Gotlib, J., Greiner, G., Gülen, T., Hartmann, K., Hermine, O., Homy, H.-P., Jawhar, M., Lange, M., Lyons, J. J., Maurer, M., Metcalfe, D. D., Nedoszytko, B., Niedoszytko, M., Orfao, A., Reiter, A., Schwaab, J., Sotlar, K., Sperr, W. R., Triggiani, M., Valent, P., and Siebenhaar, F.⁺: Refined treatment resonse criteria for indolent systemic mastocytosis proposed by the ECNM-AIM consortium. J. Allergy Clin. Immunol. Pract. 2022: 10; 2015-2024. IF: 9.40

r.188

No Access

No access You need to be logged in if you need help or have forgotten the access data, please contact me and tell me your

61.	Metz, M. and Maurer, M.: Omalizumab in chronic urticaria. Curr. Opin. Allergy Clin. Immunol. 2012: 12; 406-411. IF: 3.39

The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU

285

Maurer, M.+, Abuzakouk, M., Bérard, F., Canonica, W., Oude Elberink, H., Giménez-Arnau, A., Grattan, C., Hollis, K., Knulst, A., Lacour, J. P., Lynde, C., Marsland, A., McBride, D., Nakonechna, A., Ortiz de Frutos, J., Proctor, G., Sweeney, C., Tian, H., Weller, K., Wolin, D., and Balp, M. M.: The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy 2017: 72; 2005-2016. IF: 6.05

133	Hepworth, M. R.+, Danilowicz-Luebert, E., Rausch, S., Metz, M., Klotz, C., Maurer, M. and Hartmann, S.: Mast cells orchestrate type 2 immunity to helminths through regulation of tissue derived cytokines. P. Natl. Acad. Sci. USA 2012: 109; 6644-6649. IF: 9.73

273	Zanichelli, A., Maurer, M. Aberer, W., Caballero, T., Longhurst, H., Bouillet, L., Fabien, V., and Andresen, I.: Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice. Allergy 2017: 72; 994-998. IF: 6.05

o.273

Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4

158

Hendrix, S.+, Kramer, P., Pehl, D., Warnke, K., Boato, F., Nelissen, S., Lemmens, E., Pejler, G., Metz, M., Siebenhaar, F., and Maurer, M.: Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4. FASEB J. 2013: 27; 920-929. IF: 5.48

o.158

Omalizumab in chronic inducible urticaria: a real-life study of efficacy, safety, predictors of treatment outcome and time to response

421.

Yu, M., Terhorst-Molawi, D., Altrichter, S., Hawro, T., Chen, Y.-D., Liu, B., Song, X.-T., Zhao, Z.⁺*, and Maurer, M.⁺*: Omalizumab in chronic inducible urticaria: a real-life study of efficacy, safety, predictors of treatment outcome and time to response. Clin. Exp. Allergy 2021: 51; 730-734. IF: 5.40

o.421

397.	Chen, Y.-D., Maurer, M., Liu, B., Song, X.-T., Tu, P., and Zhao, Z.-T.⁺: Addition of omalizumab to antihistamine treatment in chronic urticaria: a real-world study in China. Ann. Allergy Asthma Immunol. 2020: 125; 217-219. IF: 6.35

o.397

324	Balp, M. M.+, Weller, K., Carboni, V., Chirilov, A., Papavassilis, C., Severin, T., Tian, H., Zuberbier, T., and Maurer, M.: Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients. Pediatr. Allergy Immunol. 2018: 29; 630-636. IF: 2.42

Results

Search Results for: Quiz 2024 EMC D-PDM-DY-23: Dell PowerProtect Data Manager Deploy 2023 Exam Updated Vce Download 🌋 Copy URL ➥ www.pdfvce.com 🡄 open and search for ⇛ D-PDM-DY-23 ⇚ to download for free 🥇Latest D-PDM-DY-23 Test Testking – Page 35